Anna O. Nyuganen

Anna O. Nyuganen

Auto-generated profile, based on publicly available information

Anna O. Nyuganen

Petrov National Medicine Research Institute of Oncology, Saint Petersburg, Russia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2019 in Obstetrics, Gynecology and Reproduction
Verified
Journal Article
Open access
PDF file
SAS. S. Aganezov
S. S. Aganezov
VEV. N. Ellinidi
V. N. Ellinidi
AMA. V. Morotskaya
A. V. Morotskaya
AAA. S. Artemyeva
A. S. Artemyeva
ANA. O. Nyuganen
A. O. Nyuganen
NAN. V. Aganezova
N. V. Aganezova
Aim:to analyze the endometrial expression of leukemia inhibitory factor (LIF) related to the estrogen/progesterone receptor endometrial status in women with the history of reproductive dysfunctions.Materials and methods.The main group consisted of patients with the history of infertility (n = 81) or early pregnancy loss (n = 40). The control group included 16 women with normal fertility. At days 6–8 after ovulation, endometrial biopsy was performed and peripheral blood samples were taken to assess the estradiol and progesterone levels. Histological and immunohistochemical (to quantify the estrogen (ER)/progesterone (PR) receptors and LIF expression) examinations of the endometrium biopsy materials were carried out.Results.In the middle phase of the secretion, women of the control group showed higher levels of LIF expression in the endometrial glands (94%; n = 15) and stroma (88 %; n = 14) significantly more often than patients with reproductive dysfunctions – 69 % (n = 84) and 44 % (n = 53) respectively (p < 0.05). There was no difference in the endometrial LIF expression between women with infertility and those with early pregnancy loss. In women with a sizable hormone-receptor 'response', a pronounced expression of LIF in the luminal epithelium (87 %; n = 52 out of 60) and stroma (68 %; n = 47 out of 69) was detected more often (p < 0.01) than that in patients with impaired hormone-receptor interactions (61 %, n = 27 of 44; 29 %, n = 20 of 68). High PR expression in the endometrial glands (H-score > 105) indicates the risk of impaired LIF expression in the luminal epithelium (OR =2.6) and stroma (OR = 2.5). Overexpression of ER (H-score > 155) in the endometrial stroma is associated with the risk of sub-normal LIF expression in the endometrial glands (OR = 2.5) and stroma (OR = 2.8).Conclusion.A meaningful connection has been found between the endometrial estrogen/progesterone receptor status and the expression of LIF. Women with well-pronounced endometrial hormone-receptor interactions show high levels of endometrial LIF expression more often. The stromal ER and glandular PR expression levels are considered to be prognostic factors of reduced endometrial LIF expression in the uterine body mucosa.

18 June 2025 in Exploration of Targeted Anti-tumor Therapy
Verified
Journal Article
Open access
PDF file
ASAnna Sokolenko
Anna Sokolenko
TGTatiana Gorodnova
Tatiana Gorodnova
DEDiana Enaldieva
Diana Enaldieva
ASAnna Shestakova
Anna Shestakova
AIAlexandr Ivantsov
Alexandr Ivantsov
EIEvgeny N. Imyanitov
Evgeny N. Imyanitov
Aim: BRCA1/2-associated breast and ovarian carcinomas are often regarded as a single entity, assuming that BRCA1 and BRCA2 genes are almost equivalent with regard to their clinical significance. However, BRCA1 and BRCA2 genes differ in their function; therefore, a comparison of treatment outcomes in BRCA1 vs. BRCA2 carriers is warranted. Methods: This study focused on consecutive patients treated with neoadjuvant chemotherapy (NACT), given that these subjects are treatment-naive and accessible for immediate assessment of pathological and clinical outcomes. Results: BRCA2-associated high-grade serous ovarian carcinomas (HGSOCs) demonstrated significantly higher rates of pathologic complete response (pCR) as compared to BRCA1-related cancers [8/15 (53%) vs. 7/48 (15%), P = 0.004]. In contrast, HER2-negative breast cancer (BC) patients showed a numerically higher rate of pCR in BRCA1 vs. BRCA2 mutation carriers [38/69 (55%) vs. 13/36 (36%), P = 0.1]. However, the comparison with BRCA-wild-type (WT) tumors revealed that this tendency was mainly attributed to the increased prevalence of hormone receptor (HR)-negative disease in the former group. When BC patients were stratified according to the tumor receptor status, the response rates in triple-negative patients were consistently higher than in HR+/HER2– patients across all analyzed subgroups [BRCA1: 35/59 (59%) vs. 3/10 (30%); BRCA2: 5/10 (50%) vs. 8/26 (31%); WT: 31/76 (41%) vs. 12/74 (16%); Mantel-Haenzsel P < 0.001]. Logistic regression analysis revealed that the odds ratio (OR) for achieving pCR was higher for receptor status (triple-negative vs. HR+: OR = 3.4, 95% CI 1.9–6.0, P < 0.001) than for BRCA status (any mutation vs. WT: OR = 2.1, 95% CI 1.2–3.6, P = 0.008). The addition of carboplatin did not improve pCR rates in BRCA1- or BRCA2-associated BCs, while there was a numerically higher efficacy of carboplatin-containing regimens in patients with WT triple-negative tumors [14/26 (54%) vs. 15/44 (34%), P = 0.13]. Conclusions: Hereditary ovarian carcinomas demonstrate better NACT outcomes in BRCA2 vs. BRCA1 mutation carriers. The opposite trend is observed in BC, which is likely to be attributed to a high frequency of triple-negative disease in BRCA1- but not BRCA2-associated BCs. Triple-negative receptor status rather than BRCA1/2 status is the strongest predictor of response to NACT in BC.

26 July 2020 in Obstetrics, Gynecology and Reproduction
Verified
Journal Article
Open access
PDF file
SAS. S. Aganezov
S. S. Aganezov
VEV. N. Ellinidi
V. N. Ellinidi
AMA. V. Morotskaya
A. V. Morotskaya
AAA. S. Artemyeva
A. S. Artemyeva
ANA. O. Nyuganen
A. O. Nyuganen
NAN. V. Aganezova
N. V. Aganezova
Aim: to evaluate the endometrial expression of e-cadherin in relation to the estrogen-progesterone-receptor status of the endometrium.Materials and methods. In total 137 women were examined including 81 patients with infertility and 40 with a history of early pregnancy loss (main group); for comparison, 16 healthy fertile women (control group) were also examined. Endometrial aspiration biopsy was performed on 6–8 days after ovulation; in parallel, a peripheral blood sample was taken to determine the levels of estradiol and progesterone. A histological and immunohistochemical study of the endometrium with determination of estrogen (ER) and progesterone (PR) receptors and e-cadherin expression was carried out.Results. All fertile women (n = 16) and only 44 % (n = 53) of patients in the main group had the normal pattern of hormonereceptor endometrial interactions, i. e., low expression of ER and PR in the endometrial glands as well as reduced expression of ER and high expression of PR in the endometrial stroma. The endometrial e-cadherin expression was assessed in the following cohorts: a) women with normal hormone-receptor interactions (16 women in the control group and 53 women in the main group); b) with abnormal variants of hormone-receptor interactions in the endometrium (68 patients in the main group). The frequency of reduced e-cadherin expression was significantly lower in the cohort of women with normal estrogenprogesterone-receptor endometrial status (a) than in the cohort of women with abnormal variants of the endometrial “response” (b): in the luminal epithelium – in 5 % (3 out of 63) (а) vs. 17 % (8 out of 47) (b) (p < 0.05); in the glands – in 13 % (9 out of 69) (a) vs. 37 % (25 out of 68) (b) (p < 0.05).Conclusion. The estrogen-progesterone-receptor status of the endometrium is significant for the e-cadherin expression in the luminal epithelium and glands of the endometrium.

14 December 2022 in Journal of oncology: diagnostic radiology and radiotherapy
Verified
Journal Article
Open access
PDF file
AMA. S. Mamontova
A. S. Mamontova
OSO. A. Smirnova
O. A. Smirnova
PGP. Yu. Grishko
P. Yu. Grishko
ANA. O. Nyuganen
A. O. Nyuganen
AKA. V. Kulish
A. V. Kulish
AMA. V. Mishchenko
A. V. Mishchenko
Мультипараметрическая магнитно-резонансная томография в определении прогностических факторов рака шейки матки IB2-IIB стадий после неоадъювантной химиотерапии

4 October 2023 in GYNECOLOGY
Verified
Journal Article
Open access
PDF file
NANatalia V. Aganezova
Natalia V. Aganezova
SASergey S. Aganezov
Sergey S. Aganezov
KGKsenia E. Gogichashvili
Ksenia E. Gogichashvili
AAAnna S. Artemyeva
Anna S. Artemyeva
ANAnna O. Nyuganen
Anna O. Nyuganen
Aim. To evaluate the expression of FOX proteins (FOXA1 and FOXA2) in the endometrium during the implantation window in women with a history of reproductive dysfunctions with different thickness of the endometrium. Materials and methods. The prospective cohort comparative study was conducted. The main group included patients with "thin" endometrium (7 mm according to ultrasound on preovulatory days; n=52), the comparison group consisted of women with normal endometrial thickness (7 mm according to ultrasound; n=62; women of both groups with reproductive dysfunctions of unknown reason), the control group included 16 healthy fertile women. Aspiration biopsy of the endometrium was performed on the 68 days after ovulation, as well as venipuncture to obtain a sample of peripheral blood to determine the levels of sex steroids (estradiol E2 and progesterone P). A combined histological and immunohistochemical study of endometrial biopsies was performed. Results. All women had ovulatory values of progesterone P16.1 nmol/l (68 days after ovulation) and normoestrogenemia (E2, pmol/l) in the blood. E2/P was similar in all groups (p0, 05). A pronounced expression of FOXA1 was noted in women with thin endometrium significantly more often (p0.05) with various hormone-receptor characteristics of the endometrium (42% n=22 out of 52) compared with healthy participants (0%; n=0). Reduced FOXA2 expression in the uterine mucosa was significantly more often detected on 68 days after ovulation in women with "thin" endometrium (56% n=29 of 52) than in women with normal endometrial thickness, both in women from the comparison group and in healthy women from the control group (p0.05). In a generalized analysis of the expression of FOX proteins in the endometrium on days 68 after ovulation, it was generally found that every second (50%; n=57 out of 114) women with a history of reproductive disorders (with a reduced and normal M-echo value) expression of proteomic markers differed from healthy women. In the case of "thin" endometrium, more than two thirds of patients (71%; n=37 out of 52) showed differences in endometrial expression of FOX proteins compared with women without a burdened reproductive history. Conclusion. In the majority of women (71%) with a thin endometrium and a history of reproductive dysfunctions, the expression of FOX proteins in the endometrium differed from the control group. Overall, endometrial expression of FOX proteins, which is likely to be different from healthy women, in patients with reproductive dysfunctions of unknown origin is a significant predictor of reproductive failure. At the same time, such an isolated indicator as M-echo value 7 mm according to ultrasound data is not an absolute prognostic marker of endometrial receptivity disorders.

27 December 2024 in Acta medica Eurasica
Verified
Journal Article
Closed access
ESEkaterina S. Samakina
Ekaterina S. Samakina
GSGleb Yu. Struchko
Gleb Yu. Struchko
LMLarisa M. Merkulova
Larisa M. Merkulova
OKOlga Yu. Kostrova
Olga Yu. Kostrova
ANAnna O. Nyuganen
Anna O. Nyuganen
The immune system, having a complex structural organization, performs the main functions in providing an anti-inflammatory and antitumor immune response. The spleen, as a peripheral organ of the immune system, plays an important role in realization of these functions and contains a significant number of immune cells. Ethylcarbamate, being a group 2A carcinogen, can provoke the development of neoplastic processes through activation of Kras gene mutation and stimulation of oncogenic signals. Alongside with that, selenium affects the immune response, reducing the proliferation of tumor cells and producing an anti-inflammatory effect. Despite the existence of several studies on the effect of ethyl carbamate and selenium on the animal body, there is no data on the combined effect of these substances on the rat spleen under experimental conditions in the scientific literature. The aim of the study was to evaluate morphological and morphometric changes in the structure of the spleen in male rats with oral administration of selenium into their body and intraperitoneal injection of ethyl carbamate. Materials and methods of the study. The body mass of male rats and their spleen were studied, morphological and morphometric parameters of the spleen were evaluated, the lymphoid coefficient and the Kernoghan index were calculated. The animals were divided into four groups: N1 – control group; N2 – animals receiving selenium with drinking water; N3 – animals injected intraperitoneally with ethyl carbamate; N4 – animals receiving selenium with drinking water followed by injection of ethyl carbamate. Results. It was found that in the group 2, the area of lymphoid nodules was reduced, the Kernoghan index was reduced and the lymphoid coefficient was increased, while the body weight of rats and their spleen remained unchanged. In a month after an isolated intake of ethyl carbamate, both the body weight and the spleen weight in rats were significantly decreased. At this, in group 3, the area and the diameter of the germinal center, the thickness of the periarterial lymphoid sheath and the Kernoghan index were increased, and the lymphoid coefficient was reduced. At the ultramicroscopic level, an increase in the number of plasma cells was detected in group N3, as well as the number of swollen mitochondria in lymphocytes. In group 4, an increase in the area and the diameter of lymphoid nodules, the germinal center, as well as the lymphoid coefficient was determined, and the Kernoghan index was unchanged. When studying ultrathin sections in group 4 lymphocytes of various transitional forms were revealed. Conclusions. It was found that against the background of selenium intake into the body of male rats, a morphological rearrangement of the white pulp of the spleen occurred, probably associated with the reaction of T-lymphocytes. Ethyl carbamate injection resulted in a predominant effect on the B-cell link of the immune response of the spleen. In combined intake of selenium and ethyl carbamate, hyperplasia of the white pulp was revealed, consisting in an increase in its structures.